Compare Matson Inc (MATX) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Matson Inc vs Zoetis Inc — how do they compare? Matson Inc trades at $225.67 (market cap $6.81B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 4.4× Matson Inc's market cap, and Zoetis Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Matson Inc for 23 Days and Zoetis Inc for 70 Days on average.
| MATX | ZTS | |
|---|---|---|
Market Cap | $6.81B | $30.20B |
Volume | 255,080 | 6,175,327 |
Sector | Industrials | Health |
52-Week High | $238.60 | $147.53 |
52-Week Low | $88.05 | $69.09 |
Typical Hold Time | 23 Days | 70 Days |
Enterprise Value | $7.41B | $37.76B |
Dividend Yield | 0.67% | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Matson (MATX) trades at $227.79, up 2.18% with strong bullish technical signals and consistent earnings beats. The stock shows robust fundamentals with 13.41% net income margin and 17.21% ROE, supported by positive analyst sentiment (66.7% buy ratings). Recent Q2 2026 earnings of $4.27 per share exceeded expectations by 12.7%, with the company raising full-year guidance amid resilient consumer demand and stable Trans-Pacific trade conditions.
Outlook remains positive with projected revenue growth to $3.5B in 2026 and improved cash flow. Key risks include freight market volatility and competitive pressures. Wall Street sees 27.3% upside potential based on average price targets, while institutional buying activity from Bank of America and Deutsche Bank signals confidence in the company's execution.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
